coramaze
Key Facts
Invested since | 2014 |
Based in | North Rhine-Westphalia |
About the company
Coramaze Technologies develops an innovative, highly differentiated, transcatheter tricuspid valve repair system, called TriPair. Headquartered in Germany with an R&D hub in Israel, we promote health equity by offering a solution that is easy to use, fast, and effective. We empower physicians in both existing and new markets, allowing them to treat patients who cannot be served with existing technologies.
Do you want to
know more about this company?
coramaze in the news

coramaze technologies raises EUR 4.5 million to advance novel transfemoral mitral valve repair system into the clinic
